Clinical Trial: Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis

Brief Summary:

This study aims to evaluate safety and efficacy of dimethyl fumarate treatment in patients with primary progressive multiple sclerosis (PPMS).

Half of the patients will receive dimethyl fumarate and the other half will receive placebo.